Listen to Gynecologic Oncology

Epizody

• 
  Do We Have the Courage? Pregnancy, Policy, and the Price Surgeons Pay 28.09.2026 41min

  Editor's Choice: Pregnancies in gynecologic oncologists: An assessment of pregnancy policies and complications within a surgical subspecialty Editorial: Pregnancy complications in gynecologic oncologists – A call to action to do better Hosted by: Paola Gehrig, MD University of Virginia , Charlottesville, United States of America Featuring: Kelsey Goon, MD University of Chicago, United States of America Kathryn A. Mills, MD University of Chicago, United States of Ame...
• 
  FIGO 2023 Upstaging: Overtreatment or Overdue Precision? 01.09.2026 31min

  Editor's Choice: FIGO 2023 staging may result in overtreatment of early-stage endometrial cancer Editorial: A path to precision in endometrial cancer management: Moving past FIGO 2023 Hosted by: David Gaffney, MD, PhD The University of Utah, Salt Lake City, Utah, United States of America Featuring: Allison Roy, MD SUNY Upstate Medical University, Syracuse, NY, United States of America Jessica N. McAlpine University of British Columbia, Vancouver, BC, Canada David Mu...
• 
  ERAS 2026: Key Updates Every Gynecologic Oncologist Should Know 31.07.2026 26min

  Editor's Choice: Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 update Editorial: The evolving landscape of personalized perioperative care: A commentary on the 2026 ERAS® Gynecologic oncology guidelines Hosted by: Sean C. Dowdy, MD; Division of Gynecologic Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA Featuring: Gregg Nelson, MD, PhD; Department of Obstetrics & Gynecology, Cumming School of Medicine, Universi...
• 
  Beyond the Binary: Unpacking Molecular Diversity in PMMR Endometrial Cancer 29.07.2026 25min

  Editor's Choice: Biomarker heterogeneity and efficacy of durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib in patients with mismatch repair proficient endometrial cancer: exploratory analyses of the DUO-E/GOG-3041/ENGOT-EN10 trial Editorial: Hitting the mark—or missing it? The promise and peril of biomarkers in endometrial cancer Hosted by: Amanda Nickles Fader, MD; Johns Hopkins Medicine Baltimore, MD, USA Featuring: Kathleen Moore, M...
• 
  Cologuard-like test for identification of endometrial cancer through vaginal sampling 13.05.2026 25min

  Editor's Choice: Optimization of methylated DNA markers to rule out endometrial cancer in patients with abnormal uterine bleeding Editorial: Tampon-based methylated DNA testing for endometrial cancer: Promising innovation, but prudence before practice Hosted by: Charles N. Landen Jr., MD; University of Virginia Charlottesville, VA, USA Featuring: Jamie N. Bakkum-Gamez, MD; Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA John B. Kisiel, MD; Division...
• 
  PARP Inhibitors in Ovarian Cancer: A Society of Gynecologic Oncology Podcast 08.05.2026 19min

  Updates in US Food and Drug Administration approvals for poly-ADP-ribose polymerase inhibitors in Ovarian Cancer: A society of gynecologic oncology clinical practice review Moderator: Ursula A. Matulonis, MD; Dana-Farber Cancer Institute Speakers: Bhavana Pothuri, MD; Perlmutter Cancer Center, NYU Langone Health Róisín E. O’Cearbhaill, MD; Gynecologic Medical Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center; Department of Medicine, Weill Cornell Medical College Yvett...
• 
  Home the Same Day? Testing the Limits in Ovarian Cancer Debulking Surgery 08.04.2026 18min

  Editor's Choice: Same day discharge after minimally invasive interval debulking surgery in advanced stage ovarian cancer Editorial: Same-day discharge in advanced ovarian cancer as a milestone of surgical evolution and patient selection Hosted by: Gregg Nelson, MD, PhD, FRCSC University of Calgary, Calgary, Alberta Canada Featuring: Surabhi Tewari, MD, Department of Obstetrics and Gynecology, Mass General Brigham, Harvard Medical School, Boston, MA, USA Alexander Melamed, MD...
• 
  Recognizing and Managing ADC-Associated Pulmonary Toxicities 16.03.2026 29min

  Editor’s Choice: Interstitial lung disease in targeted therapies: A Society of Gynecologic Oncology clinical practice statement Hosted by: Jose Alejandro Rauh-Hain, MD MPH Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Featuring: Charles A. Powell, MD, MBA Division of Pulmonary, Critical Care and Sleep Medicine, Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA Check out more...
• 
  In good SHAPE 01.02.2026 23min

  Editor's Choice: Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial Editorial: Commentary on: Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup Canadian Cance...
• 
  ctDNA-Guided PARPi Therapy in Ovarian Cancer 01.01.2026 25min

  Editor’s Choice: Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment? Editorial: Towards personalizing PARP inhibitor maintenance therapy for ovarian cancer Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology Featuring: Rebecca Arhend, University of Alabama at Birmingham, Birmingham, AL, USA Christina M. Annunziata, American Cancer Society, Atlanta, GA, USA Check out more content on the ...
• 
  Beyond treatment: The who, why, when, where and what of cancer follow up 01.12.2025 28min

  Editor’s Choice: Reconsidering follow-up care in gynaecologic oncology: A scoping review exploring alternative approaches Editorial: Who is following up? Rethinking survivorship and surveillance Hosted by: Paola A Gehrig, MD University of Virginia Charlottesville, Virginia United States Featuring: Lee-may Chen, MD; Division of Gynecologic Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, United States Esther Vermaas; Department of Obstetrics and Gynaecology,...
• 
  Ovarian Cancer After Breast Cancer in Women with BRCA Variants 20.11.2025 28min

  Editor’s Choice: Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant Editorial: Does a diagnosis of breast cancer reduce ovarian cancer risk in BRCA1/2 carriers:Why is this a question? Hosted by: John Farley, MD, COL(ret), FACOG, FACS, St Joseph's Hospital and Medical Center, Phoenix, AZ, United States of America Featuring: Steven Narod, Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada Stephanie Blank, Icahn School of Medic...
• 
  Making a difference: Molecules, mechanisms and more 17.11.2025 38min

  Editor’s Choice: A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer Editor’s Choice: Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer Editorial: From one-size-fits all to biology-driven care: Emerging paradigms in gynecologic oncology Hosted by:...
• 
  Navigating Surgical Complexity After Ovarian Cancer Neoadjuvant Chemotherapy 06.11.2025 20min

  Editor’s Choice: Surgical complexity and scope of procedures necessary after neoadjuvant chemotherapy for primary ovarian cancer Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology Featuring: William Cliby, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA Chiara Ainio, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA Oliver Zivanovic, Clinic for Gynecology and Obstetrics, Heidelberg University Hospital, Heidelberg, German...
• 
  Cervical Cancer Care in Focus: Consensus on Quality, Equity, and Radiation Therapy 26.09.2025 21min

  Editor’s Choice: Embracing and implementing the WHO cervical cancer elimination campaign goals: A consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS on minimum quality care standards for cervical cancer patients in the U.S Editorial: Health equity, disparities, and barriers to cervical cancer care in the U.S.: A consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS addressing the WHO cervical Cancer elimination campaign goals related to treatment Editorial: Minimum standards for radiat...
• 
  Beyond Anesthesia: Self-Hypnosis in ERAS Programs 29.08.2025 24min

  Editor’s Choice: Integration of self-hypnosis in an enhanced recovery after surgery program in gynecologic oncology – A prospective randomized trial Editorial: Relax - It’s evidence-based: The role of hypnosis in managing post-operative symptoms Hosted by: Jose Alejandro Rauh-Hain, MD, Associate Editor of Gynecologic Oncology Featuring: Larissa Alejandra Meyer, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United ...
• 
  Carcinosarcoma Wars: A New Hope for TROP-2 Therapeutic Targeting 14.07.2025 20min

  Editor’s Choice: TROP2 expression and therapeutic targeting in uterine carcinosarcoma Editorial: The search for new therapeutic options for uterine carcinosarcoma Hosted by: Amanda Nickles Fader, MD, Deputy Editor of Gynecologic Oncology Featuring: Britta Weigelt, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA Sara Moufarrij, Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA Katherin...
• 
  To divert or not to divert: that is the question 08.07.2025 27min

  Editor’s Choice: STOMA study SToma-leak ratio in advanced ovarian cancer surgery: Results of a restrictive policy on the use of protective stoMAs Editorial: Diverting ileostomy: An ounce of prevention, but when? Hosted by: Diane Yamada, MD, Deputy Editor of Gynecologic Oncology Featuring: Anna Fagotti, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy Virginia Vargiu, Department of Woman and Child Health and Public...
• 
  A randomized clinical trial of metformin in endometrial cancer 02.05.2025 17min

  Editor’s choice: A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG Oncology/GOG study Editorial: Rethinking metformin in advanced endometrial cancer: Scientific humility, translational challenges, and the urgency for equity Hosted by: Sean Dowdy, MD, FACS, FACOG, Associate Editor of Gynecologic Oncology Featuring: V.L. Bae-Jump, Univers...
• 
  Understanding the Implications of the Platinum-Free Interval in Endometrial Cancer 26.03.2025 16min

  Editor’s Choice: Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study Editorial: Implications of the Platinum-Free Interval in Endometrial Cancer: A Legacy Worth Leaving Behind? Hosted by: Warner Huh, MD, Deputy Editor of Gynecologic Oncology Featuring: Paulina Haight, Division of Gynecologic Oncology, Department of Obstetrics a...